Quarterly report pursuant to Section 13 or 15(d)

Restatement of Previously Issued Financial Statements (Tables)

v3.25.0.1
Restatement of Previously Issued Financial Statements (Tables)
3 Months Ended
Mar. 31, 2024
Restatement of Previously Issued Financial Statements [Abstract]  
Schedule of Balance Sheet The following tables summarize the effect of the restatement on each financial statement line item as of the dates indicated:
Balance Sheet as of March 31, 2023   As Reported     Adjustment     As Restated     Reference
Cash and cash equivalents   $ 10,597     $ 69     $ 10,666     *
Investments     10,269       (69 )     10,200     *
Accounts receivable, net     11,915       (303 )     11,612     4
Deferred income taxes     1,205       (1,205 )    
    3
Inventory     5,666       (632 )     5,034     6,8
Prepaid corporate taxes     87       (51 )     36     3
Total current assets     41,523       (2,191 )     39,332     3,4,6,8,*
                             
Intangible assets, net     5,655       (3,473 )     2,182     1
Goodwill    
      90       90     1,2
Other assets    
      23       23     1
Right of use asset - office leases     776       77       853     1
Total other assets     6,431       (3,283 )     3,148     1,2
Total assets   $ 49,147     $ (5,474 )   $ 43,673     1,2,3,4,6,8,*
                             
Accounts payable and accrued expenses   $ 2,938     $ (23 )   $ 2,915     3
Accrued payroll and related     674       6       680     *
Current portion of contingent earn-out liabilities     2,172       (1,621 )     551     1
Current portion of installment payment liabilities    
      374       374     1
Current portion of lease liability     320       66       386     1
Total current liabilities     8,398       (1,198 )     7,200     1,3,4,8,*
                             
Long-term contingent earn-out liabilities     1,595       (1,127 )     468     1
Long-term installment payment liabilities    
      132       132     1
Long-term lease liability     456       35       491     1
Total long-term liabilities     2,051       (960 )     1,091     1
Total liabilities     10,449       (2,158 )     8,291     1,3,4,8,*
                             
Additional paid-in capital     38,307       (167 )     38,140     1
Accumulated deficit     389       (3,090 )     (2,701 )   1,3,5,7,*
Accumulated other comprehensive loss    
      (59 )     (59 )   8
Total stockholders’ equity     38,698       (3,316 )     35,382     1,3,5,7,*
Total liabilities and stockholders’ equity   $ 49,147     $ (5,474 )   $ 43,673     1,3,5,7,8,*

 

Schedule of Statement of Operations
Statement of Operations for the Three Months Ended March 31, 2023   As Reported     Adjustment     As Restated     Reference
Sales   $ 15,776     $ 195     $ 15,971     5
Total sales     15,776       195       15,971     5
                             
Cost of sales     11,083       (521 )     10,562     5
Total cost of sales     11,083       (521 )     10,562     5
                             
GROSS PROFIT     4,693       716       5,409     5
                             
General and administrative expenses     6,079       (88 )     5,991     1,*
Total operating expenses     6,079       (88 )     5,991     1,*
                             
LOSS FROM OPERATIONS     (1,386 )     804       (582 )   1,5,*
                             
Other income     57       (57 )    
    1
Unrealized gain (loss) on investments     132       (132 )    
    7
Realized gain on investments    
      12       12     7
Total other income     327       (177 )     150     1,7
                             
LOSS BEFORE INCOME TAXES     (1,059 )     627       (432 )   1,5,7,*
                             
Provision for income taxes     (364 )     416       52     3
                             
NET LOSS     (695 )     211       (484 )   1,3,5,7,*
                             
NET LOSS PER COMMON SHARE                            
Basic   $ (0.04 )   $ 0.01     $ (0.03 )   1,3,5,7,*
Diluted   $ (0.04 )   $ 0.01     $ (0.03 )   1,3,5,7,*
                             
WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING                            
Basic     18,477,604       (185 )     18,477,419     *
Diluted     18,477,604       (185 )     18,477,419     *
Schedule of Statement of Stockholders’ Equity
Statement of Stockholders’ Equity for the   Common Stock     Additional
Paid-In
    Accumulated
Other
Comprehensive
    Retained
Earnings
(Accumulated
    Stock-holders’  
Three Months Ended March 31, 2023   Shares     Value     Capital     Loss     Deficit)     Equity  
Balance, March 31, 2023 (As Reported)     18,483,334     $ 2     $ 38,307     $
    $ 389     $ 38,698  
Adjustments     (186 )    
      (167 )     (59 )     (3,090 )     (3,316 )
Balance, March 31, 2023 (As Restated)     18,483,148     $ 2     $ 38,140     $ (59 )   $ (2,701 )   $ 35,382  

 

Schedule of Statement of Cash Flows
Statement of Cash Flows for the Three Months Ended March 31, 2023   As Reported     Adjustment     As Restated     Reference
CASH FLOWS FROM OPERATING ACTIVITIES:                      
Net loss   $ (695 )   $ 211     $ (484 )   1,3,5,7,*
Deferred Income Taxes (Credit)     (364)       364      
     
Depreciation and amortization     259       (111 )     148     1
Adjustment to reconcile operating lease expense to cash paid    
      24       24     *
Change in allowance for credit losses    
      19       19     4,*
Intangible asset impairment, net     (56 )     56      
    1
Noncash accretion    
      5       5     1
Unrealized gain (loss) on investments     (94 )     94      
    7
Accounts receivable, net     2,528       (408 )     2,120     4
Inventory     1,202       (309 )     893     6
Prepaid taxes    
      52       52      
Accounts payable and accrued expenses     (1,113 )     (28 )     (1,141 )   *
Accrued payroll and related     66       4       70     *
Net cash used in operating activities     (3,593 )     (27 )     (3,620 )   1,3,4,5,6,7,*
                             
CASH FLOWS FROM INVESTING ACTIVITIES:                            
Purchases of property and equipment     (285 )    
      (285 )   1,6
Proceeds from sale of investments    
      800       800     7
Purchase of investments     (396 )     (704 )     (1,100 )   7
Net cash used in investing activities     (681 )     96       (585 )   1,6,7
                             
CASH FLOWS FROM FINANCING ACTIVITIES:                            
Payment of contingent earn-out liabilities     (384 )     176       (208 )   1
Payment of installment payment liabilities    
      (175 )     (175 )   1
Net cash used in financing activities     (384 )     1       (383 )   1
                             
NET DECREASE IN CASH     (4,658 )     70       (4,588 )   1,3,4,5,6,7,*
                             
CASH - ENDING   $ 10,596     $ 70     $ 10,666     1,3,4,5,6,7,*